Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 1
2014 4
2015 4
2016 3
2017 7
2018 4
2019 2
2020 7
2021 8
2022 21
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean junwei han (259 results)?
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.
Jiang Z, Ouyang Q, Sun T, Zhang Q, Teng Y, Cui J, Wang H, Yin Y, Wang X, Zhou X, Wang Y, Sun G, Wang J, Zhang L, Yang J, Qian J, Yan M, Liu X, Yi T, Cheng Y, Li M, Zang A, Wang S, Wang C, Wu X, Cheng J, Li H, Lin Y, Geng C, Gu K, Xie C, Xiong H, Wu X, Yang J, Li Q, Chen Y, Li F, Zhang A, Zhang Y, Wu Y, Nie J, Liu Q, Wang K, Mo X, Chen L, Pan Y, Fu P, Zhang H, Pang D, Sheng Y, Han Y, Wang H, Cang S, Luo X, Yu W, Deng R, Yang C, Keegan P. Jiang Z, et al. Among authors: han y. Nat Med. 2024 Jan;30(1):249-256. doi: 10.1038/s41591-023-02677-x. Epub 2024 Jan 8. Nat Med. 2024. PMID: 38191615 Clinical Trial.
Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Gao B, Yang F, Zheng D, Hu S, Liu J, Liu H, Liu Y, Liu L, Wang R, Zhao Y, Cui C, Fang C, Yang J, Su S, Han Y, Yang X, Li B. Gao B, et al. Among authors: han y. J Hepatocell Carcinoma. 2023 Dec 13;10:2265-2276. doi: 10.2147/JHC.S443041. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 38107541 Free PMC article.
Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period.
Su K, Wang F, Li X, Chi H, Zhang J, He K, Wang Z, Wen L, Song Y, Chen J, Wu Z, Jiang Y, Li H, Gu T, Wang C, Li Y, Liu M, Guo Q, Xu K, Guo L, Han Y. Su K, et al. Among authors: han y. Front Immunol. 2023 Sep 25;14:1265959. doi: 10.3389/fimmu.2023.1265959. eCollection 2023. Front Immunol. 2023. PMID: 37818373 Free PMC article.
Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study.
Jiang Y, Guo L, Han L, Li H, Li C, Wen L, Song Y, Wang Z, Wang P, Guo Q, Zhao W, Liu M, Chen J, Wu Z, Yan Y, Xu K, Gu T, Wu X, He K, Su K, Han Y. Jiang Y, et al. Among authors: han y. J Cancer Res Clin Oncol. 2023 Nov;149(15):14271-14282. doi: 10.1007/s00432-023-05089-z. Epub 2023 Aug 10. J Cancer Res Clin Oncol. 2023. PMID: 37561208
PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis.
Li H, Su K, Guo L, Jiang Y, Xu K, Gu T, Chen J, Wu Z, Wang P, Zhang X, Yan Y, Li S, Wu X, Han L, He K, Wen L, Li B, Han Y. Li H, et al. Among authors: han y. J Hepatocell Carcinoma. 2023 Jul 29;10:1257-1266. doi: 10.2147/JHC.S415843. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37538403 Free PMC article.
73 results